PMEDF (QScreen AI) ROE %: 0.00% (As of Jan. 2026)


What is QScreen AI ROE %?

QScreen AI PMEDF -3.47% ROE % is 0.00% as of Jan. 2026. The stock has 1 warning sign investors should review. Among 797 Medical Devices & Instruments companies, QScreen AI ranks worse than 125470.39% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. QScreen AI's annualized net income for the quarter that ended in Jan. 2026 was $-1.13 Mil. QScreen AI's average Total Stockholders Equity over the quarter that ended in Jan. 2026 was $-0.56 Mil. Therefore, QScreen AI's annualized ROE % for the quarter that ended in Jan. 2026 was N/A%.

The historical rank and industry rank for QScreen AI's ROE % or its related term are showing as below:

PMEDF's ROE % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.4
* Ranked among companies with meaningful ROE % only.

QScreen AI  (OTCPK:PMEDF) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Jan. 2026 )
=Net Income/Total Stockholders Equity
=-1.128/-0.562
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-1.128 / 0)*(0 / 0.3585)*(0.3585 / -0.562)
=Net Margin %*Asset Turnover*Equity Multiplier
=N/A %*0*N/A
=ROA %*Equity Multiplier
=N/A %*N/A
=N/A %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Jan. 2026 )
=Net Income/Total Stockholders Equity
=-1.128/-0.562
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-1.128 / -1.128) * (-1.128 / -1.128) * (-1.128 / 0) * (0 / 0.3585) * (0.3585 / -0.562)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1 * 1 * N/A % * 0 * N/A
=N/A %

Note: The net income data used here is four times the quarterly (Jan. 2026) net income data. The Revenue data used here is four times the quarterly (Jan. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


QScreen AI ROE % Related Terms


QScreen AI ROE % Historical Data

* Premium members only.

The historical data trend for QScreen AI's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

QScreen AI ROE % Chart

QScreen AI Annual Data
Trend Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
ROE %
Get a 7-Day Free Trial -215.31 -523.26 0.00 0.00 0.00

QScreen AI Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PMEDF vs ABT, SYK, MDT: ROE % Comparison

For the Medical Devices subindustry, QScreen AI's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


QScreen AI ROE % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, QScreen AI's ROE % distribution charts can be found below:

* The bar in red indicates where QScreen AI's ROE % falls into.



QScreen AI ROE % Calculation

QScreen AI's annualized ROE % for the fiscal year that ended in Jan. 2026 is calculated as

ROE %=Net Income (A: Jan. 2026 )/( (Total Stockholders Equity (A: Jan. 2025 )+Total Stockholders Equity (A: Jan. 2026 ))/ count )
=-0.845/( (-0.917+-0.553)/ 2 )
=-0.845/-0.735
=N/A %

QScreen AI's annualized ROE % for the quarter that ended in Jan. 2026 is calculated as

ROE %=Net Income (Q: Jan. 2026 )/( (Total Stockholders Equity (Q: Oct. 2025 )+Total Stockholders Equity (Q: Jan. 2026 ))/ count )
=-1.128/( (-0.571+-0.553)/ 2 )
=-1.128/-0.562
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Jan. 2026) net income data. ROE % is displayed in the 30-year financial page.

* Note that if the average Total Stockholders Equity is zero or negative, then ROE % would be considered meaningless and hence not be calculated.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 0.00% mean?
QScreen AI (PMEDF) has a ROE % of 0.00% as of Jan. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on QScreen AI and its competitors. According to the industry distribution chart, QScreen AI ranks #999999 out of 797 companies in the Medical Devices & Instruments industry.
Is QScreen AI's ROE % too high?
QScreen AI's current ROE % is 0.00%. Based on the distribution chart, QScreen AI ranks #999999 out of 797 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does QScreen AI's ROE % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, QScreen AI ranks #999999 out of 797 companies for ROE %. This places QScreen AI in the lower half of its industry. The industry median ROE % is 2.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Devices & Instruments company?
The median ROE % among Medical Devices & Instruments companies is 2.40, based on 797 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on QScreen AI and its competitors. For the Medical Devices & Instruments industry, the median ROE % is 2.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. QScreen AI's current ROE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QScreen AI stock overvalued right now?
QScreen AI (PMEDF) has a current ROE % of 0.00%. The current ROE % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For QScreen AI (PMEDF), the current ROE % is 0.00% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

QScreen AI Business Description

Other Exchanges 3QP:GermanyQAI:Canada
Address 40 King Street West, Suite 2400, P.O. Box 215, Scotia Plaza, Toronto, ON, CAN, M5H 3Y2
QScreen AI Inc is focused on developing artificial intelligence (AI) powered technologies for general workplace health and safety, and for the health care industry. The company's business is focused on artificial intelligence (AI) technologies targeting two specific areas: workplace health and safety and healthcare. It is building a proprietary artificial intelligence engine with quantum inspired computing and physiological sensing to clinical and occupational health assessments across correctional facilities, addiction medicine rehabilitation, and industrial workforce screening in multiple jurisdictions. It operates in single segment.